• Second Round of Abstract Submission Ends: March 14, 2025
  • Early Registration Ends: March 14, 2025
  • AI and Machine Learning in Drug Discovery
  • Precision Medicine
  • Novel Therapeutic strategies
  • Therapeutic areas
  • Drug Metabolism & Pharmacokinetics
  • Drug Designing
  • Lead Optimization
  • Bioinformatics and Data Integration
  • Regenerative Medicine
  • Clinical Trial Innovations
  • Natural Products and Drug Discovery
  • Immunotherapy Developments
  • Pharmacogenomics
  • Sustainability in Drug Discovery
  • CRISPR and Gene Editing
  • Targeted Drug Delivery Systems
  • Drug Repurposing Strategies
  • Ethics in Drug Development
  • Vaccine Development Innovations
  • Patient-Centric Drug Development
  • High-Throughput Screening Techniques
  • Regulatory Challenges in Drug Discovery
  • Structure-Activity Relationship (SAR) Studies
  • Medicinal Chemistry Innovations
  • Formulation Development
  • Predictive Toxicology
  • ADMET Profiling
  • Virtual Screening and Docking Studies
  • Fragment-Based Drug Design
  • In Vitro and In Vivo Models for Lead Testing